Drugs / sialyl Lewisª-keyhole limpet hemocyanin conjugate vaccine
sialyl Lewisª-keyhole limpet hemocyanin conjugate vaccine
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| — | NCT00470574 | Mar 2007 → Jan 2020 | breast cancer | Memorial Sloan Kettering Cancer Center | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | sialyl Lewisª-keyhole limpet hemocyanin conjugate vaccine | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00470574 ↗ |
| Modality | Vaccine | “Vaccine Therapy” NCT00470574 ↗ |
| Route | Subcutaneous | “sialyl Lewisª -keyhole limpet hemocyanin conjugate vaccine subcutaneously (SC)” NCT00470574 ↗ |